Trident Growth Fund, L.P.
Records under this name other than patents Trident Growth Fund, L.P. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Trident Growth Fund, L.P.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,273,889 | Nmda Receptor Antagonist Formulation with Reduced Neurotoxicity Formerly held Term ended Term ended Jul 10, 2023 · High confidence | Term ended | Term ended Jul 10, 2023 | High confidence |
| US 7,257,557 | Multi-modal testing methodology Formerly held Lapsed on the fee record Ended Aug 14, 2011 · USPTO record | Lapsed on the fee record | Ended Aug 14, 2011 | USPTO record |